Related Experiment Video
Updated: Nov 21, 2025

03:42
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
1.8K
Exercise reduces hyperlipidemia-induced kidney damage in apolipoprotein E-deficient mice
Chengsi Qian1, Qin Yang2, Lipeng Guo3
1Department of Cardiology, Zhejiang Province Rongjun Hospital, Jiaxing, Zhejiang 314000, P.R. China.
Experimental and Therapeutic Medicine
|January 18, 2021
Summary
Exercise helps protect kidneys from hyperlipidemia-induced damage. Studies show exercise reduces kidney damage by improving metabolic parameters and decreasing oxidative stress and fibrosis markers.
Area of Science:
- Nephrology
- Cardiovascular Science
- Exercise Physiology
Background:
- Hyperlipidemia is a significant risk factor for kidney damage and chronic kidney disease.
- While exercise is known to mitigate kidney damage, the precise mechanisms are not fully understood.
Purpose of the Study:
- To investigate the protective mechanisms of exercise against hyperlipidemia-induced kidney damage in apolipoprotein E-deficient (ApoE-/-) mice.
Main Methods:
- Apolipoprotein E-deficient (ApoE-/-) mice were fed either a normal or high-fat diet and subjected to a 12-week swimming exercise regimen.
- Metabolic parameters, oxidative stress markers (glutathione peroxidase, superoxide dismutase), fibrosis markers (Smad3, TGF-β), and NF-κB expression were analyzed.
Main Results:
- Mice on a high-fat diet with exercise showed improved metabolic parameters and reduced kidney damage compared to sedentary mice.
- Exercise significantly decreased oxidative stress and fibrosis markers, including nuclear factor erythroid-2-related factor 2, Smad3, TGF-β, and NF-κB.
Conclusions:
- Exercise demonstrates protective effects against kidney damage associated with hyperlipidemia.
- These benefits are mediated through the reduction of oxidative stress and fibrotic pathways in the kidneys.
Related Concept Videos
Atherosclerosis III: Management
114
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
114
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K

